We are live on ! Find out more
FCE

Fiera Capital (Europe) Portfolio holdings

AUM $213M
1-Year Est. Return 42.35%
This Fund
S&P 500
This Quarter Est. Return
+4%
1 Year Est. Return
+42.35%
3 Year Est. Return
+41.33%
5 Year Est. Return
10 Year Est. Return
AUM
$178M
AUM Growth
+$8.81M
Cap. Flow
+$4.33M
Cap. Flow %
2.43%
Top 10 Hldgs %
76.99%
Holding
56
New
35
Increased
9
Reduced
7
Closed
5

Sector Composition

Rank Sector Weight
1 Financials 23.48%
2 Consumer Staples 22.48%
3 Communication Services 20.79%
4 Materials 10.79%
5 Energy 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
26
AbbVie
ABBV
$435B
$199K 0.11%
+3,763
New +$185K
AMGN icon
27
Amgen
AMGN
$222B
$157K 0.09%
+1,380
New +$157K
SNY icon
28
Sanofi
SNY
$104B
$144K 0.08%
+2,700
New +$139K
BMY icon
29
Bristol-Myers Squibb
BMY
$132B
$143K 0.08%
+2,700
New +$138K
BIIB icon
30
Biogen
BIIB
$30.7B
$122K 0.07%
+436
New +$113K
AGN
31
DELISTED
Allergan Inc
AGN
$109K 0.06%
+976
New +$93.2K
ILMN icon
32
Illumina
ILMN
$28.4B
$105K 0.06%
+979
New +$89.7K
CELG
33
DELISTED
Celgene Corp
CELG
$95K 0.05%
+1,126
New +$89.1K
MDT icon
34
Medtronic
MDT
$112B
$94K 0.05%
+1,641
New +$93K
INVA icon
35
Innoviva
INVA
$1.48B
$90K 0.05%
+3,146
New +$92K
REGN icon
36
Regeneron Pharmaceuticals
REGN
$80.8B
$90K 0.05%
+325
New +$93.5K
BAX icon
37
Baxter International
BAX
$14.2B
$78K 0.04%
+2,064
New +$74.9K
FRX
38
DELISTED
FOREST LABORATORIES INC
FRX
$67K 0.04%
+1,112
New +$56K
ABT icon
39
Abbott
ABT
$187B
$64K 0.04%
+1,673
New +$61.7K
VTRS icon
40
Viatris
VTRS
$18.9B
$63K 0.04%
+1,451
New +$59.6K
SPPI
41
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$38K 0.02%
+4,300
New +$38.4K
IQV icon
42
IQVIA
IQV
$39.3B
$35K 0.02%
+746
New +$32.7K
BSX icon
43
Boston Scientific
BSX
$71.5B
$33K 0.02%
+2,761
New +$32.6K
SLXP
44
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$33K 0.02%
+370
New +$29.5K
CVD
45
DELISTED
COVANCE INC.
CVD
$33K 0.02%
+375
New +$32.5K
CBST
46
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$33K 0.02%
+477
New +$30.9K
WAT icon
47
Waters Corp
WAT
$39.9B
$32K 0.02%
+315
New +$31.8K
MDVN
48
DELISTED
MEDIVATION, INC.
MDVN
$32K 0.02%
+1,002
New +$30.3K
BMRN icon
49
BioMarin Pharmaceuticals
BMRN
$12.4B
$31K 0.02%
+446
New +$30.3K
LIFE
50
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
$31K 0.02%
+414
New +$31.2K

Similar funds

Fiera Capital (Europe)'s Q4 2013 Portfolio in Review

As of Q4 2013, Fiera Capital (Europe) held 56 positions worth $178M, up 5.2% from $169M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Fiera Capital (Europe)'s Q4 2013 filing shows 35 new, 9 increased, 7 reduced and 5 closed positions. Its largest new stake was Vale: 1,231,395 shares worth $18.8M. The largest sale was COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH, an estimated $10.4M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 26% a quarter earlier, followed by Consumer Staples and Communication Services.

  • Fiera Capital (Europe)'s largest Q4 2013 buy was Vale: 1,231,395 shares worth $18.8M.
  • Fiera Capital (Europe) added most to BRF SA in Q4 2013, an estimated $3.41M increase.
  • Fiera Capital (Europe)'s biggest Q4 2013 reduction was Baidu, cutting an estimated $3.79M.
  • Fiera Capital (Europe) fully exited COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH in Q4 2013, selling an estimated $10.4M.
  • Fiera Capital (Europe)'s ten largest holdings make up 77% of its $178M portfolio in Q4 2013.
  • Fiera Capital (Europe) opened 35 new positions and closed 5 in Q4 2013.
  • Fiera Capital (Europe)'s portfolio value rose 5.2% quarter-over-quarter to $178M.

Based on Fiera Capital (Europe)'s 13F filing for Q4 2013, filed 11 Feb 2014.